References
- Clin. Microbiol. Infect. v.5 Pharmacokinetics of teicoplanin during plasma exchange Alet,P.;O.Lortholary;F.Fauvelle;M.Tod;T.Genereau;M.Louchahi;A.Leon;L.Guillevin;O.Petitjean https://doi.org/10.1111/j.1469-0691.1999.tb00126.x
- Antimicrob. Agents Chemother. v.35 Randomized study of vancomycin versus teicoplanin for the treatment of Gram positive bacterial infections in immunocompromised hosts Auwera,P.V.;M.Aoun;F.Meunier https://doi.org/10.1128/AAC.35.3.451
- Ther. Drug Monit. v.13 Teicoplanin measurement in patients with renal failure:Comparison of fluorescene in patiests with real failure:Comparison of fluorescence polarization immunoassay,microbiological assay,and high-performance liquid chromatographic assay Awni,W.M.;W.L.St Peter;D.R.Guay;M.T.Kenny;G.R.Matzke https://doi.org/10.1097/00007691-199111000-00008
- J. Antibiot. v.31 Teichomycins,new antibiotics from Actinoplanes teicomyceticus nov.sp. Bardone,M.R.;M.Paternoster;C.Coronelli https://doi.org/10.7164/antibiotics.31.170
- Annu. Rev. Microbiol. v.38 The structure and mode of action of glycopeptide antibiotics of the vancomycin group Barna,J.C.J.;D.H.William https://doi.org/10.1146/annurev.mi.38.100184.002011
- Methods Enzymol. v.70 The use of carbodimides in the preparation of immunizing conjugates Bauminger,S.;W.Wilchek https://doi.org/10.1016/S0076-6879(80)70046-0
- Antimicrob. Agents Chemother. v.36 Teicoplanin metabolism in humans Bernareggi,A.;A.Borghi;M.Borgonovi;L.Cavenaghi;P.Ferrari;K.Vekey;M.Zanol;L.F.Zerilli https://doi.org/10.1128/AAC.36.8.1744
- Antimicrob. Agents Chemother. v.31 Clinical evaluation of efficacy,pharmacokinetics,and safety of teicoplanin for serious Gram-positive infections Bibler,M.R.;T.F.Peter;D.N.Hagler;R.B.Bode;J.L.Staneck;V.Thamlikitkul https://doi.org/10.1128/AAC.31.2.207
- J. Antibiot. v.37 Teicomycins,new antibiotics from Actinoplanes teicomyceticus nov.sp.Ⅳ.Separation and characterization of the components of teicomycin(teicoplanin) Borghi,A.;C.Coronelli;L.Faniuolo;G.Allievi;R.Pallanza;G.G.Gallo https://doi.org/10.7164/antibiotics.37.615
- Drugs v.47 Teicoplanin.A reappraisal of its antimicrobial activity,pharmacokinetic properties and therapeutic efficacy Brogden,R.N.;D.H.Peters;R.N.Brogden;D.H.Peters https://doi.org/10.2165/00003495-199447050-00008
- J. Hosp. Infect. v.7 Comparison of the solid-phase enzyme-receptor assay(SPERA)and the microbiological assay for teicoplanin Cavenaghi,L.;A.Corti;G.Cassani https://doi.org/10.1016/0195-6701(86)90012-5
- Clin. Chem. v.33 A receptor-antibody sandwich assay for teicoplanin Corti,A.;L.Cavenaghi;E.Giani;G.Cassani
- Clin. Chem. v.31 Solid phase enzyme-receptor assay(SPERA):A competitive binding assay for antibiotics of the vancomycin class Corti,A.;C.Rurali;A.Borghi;G.Cassani
- J. Chromatogr. v.529 Interfacing microbore and capillary liquid chromatography to continuous-flow fast atom bombardment mass spectrometry for the analysis of glycopeptides Coutant,J.E.;T.M.Chen;B.L.Ackermann https://doi.org/10.1016/S0378-4347(00)83833-5
- Antimicrob. Agents Chemother. v.37 Evaluation of a novel fluorescence polarization immunoassay for teicoplanin Cox,H.;M.Whitby;G.Nimmo;G.Williams https://doi.org/10.1128/AAC.37.9.1924
- Comb. Chem. High Throughput Screen v.6 Fluorescence polarization immunoassay for pesticides Eremin,S.A.;D.S.Smith https://doi.org/10.2174/138620703106298301
- Antimicrob. Agents Chemother. v.31 Pharmacokinetics of teicoplanin in renal failure Falcoz,C.;N.Ferry;N.Pozet;G.Cuisinaud;P.Y.Zech;J.Sassard https://doi.org/10.1128/AAC.31.8.1255
- Antimocrob. Agents Chemother. v.34 Percentages and distribution of teicoplanin and vancomycin resistant strains among coagulase negative Staphylococci Goldstein,F.W.;A.Coutrot;A.Sieffer;J.F.Acor https://doi.org/10.1128/AAC.34.5.899
-
J. Biol. Chem.
v.275
Biosynthetic studies of the glycopeptide teicoplanin by ¹H and
$^13C$ NMR Heydorn,A.;B.O.Petersen;J.Ø.Duus;S.Bergmann;T.Suhr-Jessen;J.Nielsen https://doi.org/10.1074/jbc.275.9.6201 - Antimicrob. Agents Chemother. v.31 Determination of teicoplanin concentrations inserum by high-pressure liquid chromatography Joos,B.;R.Luthy https://doi.org/10.1128/AAC.31.8.1222
- J. Microbiol. Biotechnol. v.13 Detection of miotic centromere-associated kinesin(MCAK)during cell cycle progression of human jurkat T cells using polyclonal antibody raised against its N-terminla region overexpressed in E.coli Jun,D.Y.;S.W.Rue;B.W.Kim;Y.H.Kim
- Antimicorb. Agents Chemother. v.34 Application of a modified bioassay for monitoring serum teicoplanin and vancomycin in febrile neutropensic patients Kureishi,A.;P.J.Jewesson;K.H.Bartlett;C.D.Cole;A.W.Chow https://doi.org/10.1128/AAC.34.9.1642
- Nature v.227 Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Laemmli,U.K. https://doi.org/10.1038/227680a0
- Lett. Appl. Microbiol. v.37 Improved production of teicoplanin using adsorbent resin in fermentations Lee,J.C.;H.R.Park;D.J.park;H.B.Lee;Y.B.Kim;C.J.Kim https://doi.org/10.1046/j.1472-765X.2003.01409.x
- Diagn. Microbiol. Infect. Dis. v.16 Performance of a fluorescence polarization immunoassay for teicoplanin in serum Mastin,S.H.;R.L.Buck;P.A.Mueggler https://doi.org/10.1016/0732-8893(93)90125-Q
- J, Antimicrob. Chemother. v.50 Assay of teicoplanin in serum:Comparison of high-performnace liquid chromatography and fluorescence polarization immunoassay McCann,S.J.;L.O.White;B.Keevil https://doi.org/10.1093/jac/dkf067
- J. Antimicrob. Chemother. v.34 Assay of serum teicoplanin concentrations in clinical specimens:A comparison of isocratic high performance liquid chromatography with polarisation fluoroimmunoassay and bioassay McMullin,C.M.;L.O.White;A.P.MacGowan;H.A.Holt;A.M.Lovering;D.S.Reeves https://doi.org/10.1093/jac/34.3.425
- Diagn. Microbiol. Infect. Dis. v.16 Performance of a fluorescence polarization immunoassay for teicoplanin in serum Mastin,S.H.;R.L.Buck;P.A.Mueggler https://doi.org/10.1016/0732-8893(93)90125-Q
- J. Antimicrob. Chemother. v.9 The basis of immunoassay for antibiotics Munro,A.J.;J.Landon;E.J.Shaw https://doi.org/10.1093/jac/9.6.423
- J. Antibiot. v.31 Teichomycins,new antibiotics from Actinoplanes teichomyceticus nov.sp.Ⅰ.Description of the producer strain,fermentation studies and biological properties Parenti,F.;G.Beretta;M.Berti;V.Arioli https://doi.org/10.7164/antibiotics.31.276
- J. Antimicrob. Chemother. v.51 Teicoplanin therapeutic drug monitoring in critically ill patients:A retropective study emphasizing the importance of a loading dose Pea,F.;L.Brollo;P.Viale;F.Pavan;M.Furlanut https://doi.org/10.1093/jac/dkg147
- Eur. J. Clin. Microbiol. Infect. Dis. v.8 Structure,biochemistry and mechanism of action of glycopeptide antibiotics Reynolds,P.E. https://doi.org/10.1007/BF01967563
- J. Chromatogr. v.421 Determination of teicoplanin in human plasma and urine by affinity and reversed-phase high performance liquid chromatography Riva,E.;N.Ferry;A.Cometti;G.Cuisinaud;G.G.Gallo;J.Sassard https://doi.org/10.1016/0378-4347(87)80383-3
- Antimicrob. Agents Chemother v.26 Teicoplanin,a new antibioatic from Actinoplanes teicomyceticus sp.nov.:Mechanism of action. Somma,S.;L.Gastaddo;A.Corti https://doi.org/10.1128/AAC.26.6.917
- J. Chromatogr. v.563 Determination of teicoplanin in plasma using microbore high-performance liquid chromatography and injection generated gradients Taylor,R.B.;R.G.Reid;I.M.Gould https://doi.org/10.1016/0378-4347(91)80055-H
- J. Hosp. Infect. v.7 Teicoplanin in the treatment of infections caused by Gram-positive organisms Williams,A.H.;R.N.Gruneberg;A.Webster;G.I.Ridgway https://doi.org/10.1016/0195-6701(86)90014-9
- Clin. Pharmacokinet. v.39 Clinical pharmacokinetics of teicoplanin Wilson,A.P. https://doi.org/10.2165/00003088-200039030-00001